Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
The randomized, double-blind, sham-controlled trial evaluated 56 adults with ADHD who received four weeks of Nexalin’s ...
A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device ...
HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office ...
Currently, the MyoRegulator® device is under investigation as a non-invasive treatment for ALS in a second and larger clinical trial, the CALM ( C ontrolling A myotrophic L ateral Sclerosis M otor ...
WILLOW SPRINGS, Ill. (WGN) — There has been an extraordinary step forward in the treatment of spinal cord injuries. For the patients who come through the door of the Next Steps clinic in southwest ...
Interesting Engineering on MSN
Noninvasive brain stimulation device can help treat depression, PTSD, addiction
To combat a severe mental health crisis in the US, researchers invented a groundbreaking new method to reach deep brain ...
News Medical on MSN
Brain stimulation device cleared for ADHD in the US is overall safe but ineffective
Evidence from a new large UK multicentre trial is challenging the results from a previous smaller US trial that led to the ...
LumiMind debuts real-time non-invasive brain computer interfaces at CES 2026, pairing live gameplay demos with LumiSleep, a ...
HOUSTON, TEXAS, June 20, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced that the United States Patent and Trademark Office ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback